News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current ACHV market cap is 122.55M. The company's latest EPS is USD -2.0009 and P/E is -2.89.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.07M | -12.64M | -10.86M | -8.58M | -7.71M |
| Net Income | -10.47M | -13.08M | -11.23M | -8.99M | -8.24M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -12.81M | -16.53M | -14.75M | -33.09M | -40.8M |
| Net Income | -12.69M | -16.4M | -14.73M | -33.15M | -42.35M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 33.99M | 23.72M | 29.97M | 20.8M | 28.92M |
| Total Liabilities | 20.82M | 22.68M | 21.67M | 20.36M | 19.22M |
| Total Equity | 13.17M | 1.04M | 8.3M | 443k | 9.7M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 19.08M | 21.08M | 40.3M | 47.52M | 29.97M |
| Total Liabilities | 3.28M | 3.03M | 3.01M | 19.47M | 21.67M |
| Total Equity | 15.8M | 18.05M | 37.29M | 28.04M | 8.3M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -15.1M | -26.41M | -37.55M | -8.3M | -14.98M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 1.46M | 1.58M | 19.3M | 47k | 15.28M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -10.62M | -15.22M | -13.47M | -29.44M | -37.55M |
| Investing | -5.13M | 5.04M | -17k | N/A | N/A |
| Financing | 19.76M | 17.33M | 32.68M | 36.61M | 19.3M |
| Market Cap | 122.55M |
| Price to Earnings Ratio | -2.89 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.95 |
| Price to Book Ratio | 14.76 |
| Dividend Yield | - |
| Shares Outstanding | 21.17M |
| Average Volume (1 week) | 34.71k |
| Average Volume (1 Month) | 40.9k |
| 52 Week Change | 107.53% |
| 52 Week High | 10.30 |
| 52 Week Low | 2.36 |
| Spread (Intraday) | 0.25 (4.17%) |
| Company Name | Achieve Life Sciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.achievelifesciences.com |
| Industry | drugs-health r&d/testing labs (H8) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
